Meningitis b vaccine

A.L. Zomer; Jan Theunis Poolman

Meningitis b vaccine

A.L. Zomer (Inventor), Jan Theunis Poolman (Inventor)

Janssen

Research output: Patent › Other research output

Abstract

Compositions, including vaccine compositions, are provided comprising outer membrane vesicles (OMVs) from N. meningitidis B (MenB). Also provided are methods of making such compositions comprising growing MenB in culture and isolating the OMVs produced, and the use of MenB vaccine compositions for prevention of meningitis in a subject.

Original language	English
Patent number	WO 2016083583 A1
Priority date	28/11/14
Publication status	Published - 6 Feb 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@misc{8ad2fa6889284edb94601770fd8517c0,

title = "Meningitis b vaccine",

abstract = "Compositions, including vaccine compositions, are provided comprising outer membrane vesicles (OMVs) from N. meningitidis B (MenB). Also provided are methods of making such compositions comprising growing MenB in culture and isolating the OMVs produced, and the use of MenB vaccine compositions for prevention of meningitis in a subject.",

author = "A.L. Zomer and Poolman, {Jan Theunis}",

year = "2016",

month = feb,

day = "6",

language = "English",

type = "Patent",

note = "WO 2016083583 A1",

}

TY - PAT

T1 - Meningitis b vaccine

AU - Zomer, A.L.

AU - Poolman, Jan Theunis

PY - 2016/2/6

Y1 - 2016/2/6

N2 - Compositions, including vaccine compositions, are provided comprising outer membrane vesicles (OMVs) from N. meningitidis B (MenB). Also provided are methods of making such compositions comprising growing MenB in culture and isolating the OMVs produced, and the use of MenB vaccine compositions for prevention of meningitis in a subject.

AB - Compositions, including vaccine compositions, are provided comprising outer membrane vesicles (OMVs) from N. meningitidis B (MenB). Also provided are methods of making such compositions comprising growing MenB in culture and isolating the OMVs produced, and the use of MenB vaccine compositions for prevention of meningitis in a subject.

M3 - Patent

M1 - WO 2016083583 A1

ER -

Meningitis b vaccine

Abstract

UN SDGs

Fingerprint

Cite this